[PUBMED Abstract] Subbiah V, Hu MI, Wirth LJ, et al.: Pralsetinib for patients with advanced or metastatic RET-altered thyroid cancer (ARROW): a multi-cohort, open-label, registrational, phase 1/2 study
While there is no definitive accounting for how many patients are taking compounded GLP-1 meds, Alliance for Pharmacy Compounding CEO Scott Brunner tells WIRED that he estimates that the number is in the millions
How do you prepare a 510(k) submission
Animal studies using oral BPC-157 at roughly 2-10 mcg/kg show measurable GI healing effects, but no published human RCT has confirmed this translates to people at any dose
Adding Pendulum on top of an existing probiotic regimen can create an overcrowded introduction of bacterial strains
beta-Hydroxylation of trimethyllysine by an alpha-ketoglutarate-dependent mitochondrial dioxygenase